Back to Search

JAMES MOSES, M.D.

M.D.

Ophthalmology Physician

NPI: 1831187194IndividualAccepts Medicare

Specialties, Licenses & Credentials

Ophthalmology PhysicianPrimary

Ophthalmology

Code: 207W00000X

35.037237(OH)

CMS Specialties

PrimaryOPHTHALMOLOGY

Education

CLVLND CLINIC LERNER COLLEGE OF MED OF CASE WSTN RSV UNIVERSITY

Class of 1973

Research & Publications (20)

The growing applications of click chemistry.
PMID 17619685·Chem Soc Rev·2007
6-review
Sir Jack Baldwin, FRS: biomimetic studies at Oxford.
PMID 16333494·Chem Commun (Camb)·2005
8-other
Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
PMID 18804877·Int J Cardiol·2010
4-observational
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
PMID 19463408·JACC Cardiovasc Interv·2009
4-observational
Temporal optimization of ultrabroadband high-energy OPCPA.
PMID 19333322·Opt Express·2009
8-other
Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
PMID 19539252·JACC Cardiovasc Interv·2009
4-observational
G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro and in vivo.
PMID 19475728·Biochem Pharmacol·2009
4-observational
A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis.
PMID 19463466·JACC Cardiovasc Interv·2009
4-observational
Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.
PMID 19463409·JACC Cardiovasc Interv·2009
8-other
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.
PMID 19351691·Eur Heart J·2009
2-rct

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
1600 GATEWAY CIR
GROVE CITY, OH 43123

Quick Facts

NPI
1831187194
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
53
Publications
20

Are you this provider?

Claim Your Profile